Goodwill and Intangible Assets

12 Months Ended

Jan. 31, 2019

NOTE 6 — GOODWILL AND INTANGIBLE ASSETS

Intangible assets consist of the following:


	January 31, 2019
	Estimated			Accumulated
	Useful Life	Gross Assets		Amortization		Net Assets
Finite-lived assets:
Client relationships	5-10 years	$	5,397,000	$	3,756,000	$	1,641,000
Covenants not to compete	3 years		130,000		102,000		28,000
Total		$	5,527,000	$	3,858,000	$	1,669,000


	January 31, 2018
	Estimated			Accumulated
	Useful Life	Gross Assets		Amortization		Net Assets
Finite-lived assets:
Client relationships	5-15 years		5,805,000		3,308,000		2,497,000
Covenants not to compete	0.5-15 years		986,000		823,000		163,000
Supplier agreements	5 years		1,582,000		1,582,000		—
License agreement	15 years		4,431,000		1,256,000		3,175,000
Total		$	12,804,000	$	6,969,000	$	5,835,000

In fiscal 2018, we recognized an impairment charge of $3,681,000 as the carrying value of finite-lived intangible assets and capitalized product development cost relating to our Clinical Analytics solution no longer appeared recoverable. This impairment charge is included in the “Impairment of long-lived assets” line in our consolidated statements of operations for the year ended January 31, 2019. See Note 12 – Commitments and Contingencies for royalty liability associated with our Clinical Analytics solution.

Future amortization expense for intangible assets is estimated as follows:


	Annual Amortization Expense
2019	$	554,000
2020		491,000
2021		455,000
2022		169,000
Total	$	1,669,000

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details